Early eplerenone treatment in patients with acute ST-elevation myocardial infarction without heart failure: the Randomized Double-Blind Reminder Study (Q28239094)

From Wikidata

Jump to navigation Jump to search

scientific article (publication date: 7 September 2014)

Early eplerenone treatment in patients with acute ST-elevation myocardial infarction without heart failure: The Randomized Double-Blind Reminder Study

Language	Label	Description	Also known as
English	Early eplerenone treatment in patients with acute ST-elevation myocardial infarction without heart failure: the Randomized Double-Blind Reminder Study	scientific article (publication date: 7 September 2014)	Early eplerenone treatment in patients with acute ST-elevation myocardial infarction without heart failure: The Randomized Double-Blind Reminder Study

Statements

scholarly article

0 references

Early eplerenone treatment in patients with acute ST-elevation myocardial infarction without heart failure: the Randomized Double-Blind Reminder Study (English)

0 references

0 references

myocardial infarction

1 reference

based on heuristic

inferred from title

Gilles Montalescot

1

0 references

11

object named as

Faiez Zannad

0 references

2

object named as

Bertram Pitt

0 references

6

object named as

Freek Verheugt

0 references

7

object named as

Harry Shi

0 references

8

object named as

Eva Turgonyi

0 references

9

object named as

Miguel Orri

0 references

author name string

Esteban Lopez de Sa

3

0 references

Christian W Hamm

4

0 references

Marcus Flather

5

0 references

John Vincent

10

0 references

language of work or name

0 references

publication date

7 September 2014

0 references

European Heart Journal

0 references

35

0 references

34

0 references

2295-302

0 references

Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU164

21 January 2018

Intravenous enoxaparin or unfractionated heparin in primary percutaneous coronary intervention for ST-elevation myocardial infarction: the international randomised open-label ATOLL trial.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU164

21 January 2018

Effect of MR blockade on collagen formation and cardiovascular disease with a specific emphasis on heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU164

21 January 2018

Aldosterone: cardiovascular assault.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU164

21 January 2018

Plasma aldosterone levels during hospitalization are predictive of survival post-myocardial infarction

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU164

21 January 2018

ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC)

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU164

21 January 2018

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU164

21 January 2018

Timing of eplerenone initiation and outcomes in patients with heart failure after acute myocardial infarction complicated by left ventricular systolic dysfunction: insights from the EPHESUS trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU164

21 January 2018

Immediate administration of mineralocorticoid receptor antagonist spironolactone prevents post-infarct left ventricular remodeling associated with suppression of a marker of myocardial collagen synthesis in patients with first anterior acute myocard

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU164

21 January 2018

Immediate mineralocorticoid receptor blockade improves myocardial infarct healing by modulation of the inflammatory response

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU164

21 January 2018

NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU164

21 January 2018

Usefulness of biomarker strategy to improve GRACE score's prediction performance in patients with non-ST-segment elevation acute coronary syndrome and low event rates

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU164

21 January 2018

Evidence-based medication and revascularization: powerful tools in the management of patients with diabetes and coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU164

21 January 2018

Temporal trends and predictors in the use of aldosterone antagonists post-acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU164

21 January 2018

Aldosterone receptor antagonist use after myocardial infarction. Data from the REICIAM registry

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU164

21 January 2018

Early mineralocorticoid receptor blockade in primary percutaneous coronary intervention for ST-elevation myocardial infarction is associated with a reduction of life-threatening ventricular arrhythmia

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU164

21 January 2018

The effect of aldosterone antagonists for ventricular arrhythmia: a meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU164

21 January 2018

B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU164

21 January 2018

The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU164

21 January 2018

N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU164

21 January 2018

Patients with acute coronary syndromes and elevated levels of natriuretic peptides: the results of the AVANT GARDE-TIMI 43 Trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU164

21 January 2018

Serum Potassium Levels and Mortality in Acute Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU164

21 January 2018

Identifiers

10.1093/EURHEARTJ/EHU164

0 references

release_c4kfm7hyenc7hkm3mc7zuxnbja

1 reference

https://api.fatcat.wiki/v0/release/c4kfm7hyenc7hkm3mc7zuxnbja

24 November 2022

based on heuristic

mapped directly with Wikidata item

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28239094&oldid=1835812277"